• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
ATTD 2011 3e

ATTD 2011 3e

Hardcover

Health GeneralMedical Reference

ISBN10: 1118279298
ISBN13: 9781118279298
Publisher: John Wiley & Sons
Published: Mar 15 2012
Pages: 296
Weight: 1.49
Height: 0.69 Width: 6.69 Depth: 9.61
Language: English
The traditional agents for controlling the levels of glucose in the blood remain important therapies but they have their downside from the point of view of tolerability and side effects. Moreover, they appear not to be able to counter the natural history deterioration of the disease in terms of the onset of diabetic-related complications.

Recent years have seen an influx of new treatment therapies and technologies aimed at achieving better glycaemic control for diabetic patients such as liraglutide (Novo Nordisk) and saxagliptin (BMS/Astra-Zeneca) and insulin pumps, away from the more traditional therapies used (classic insulin therapy, oral hypoglycaemics).

Also in

Medical Reference